Literature DB >> 21415688

Development and initial validation of the assessment of caregiver experience with neuromuscular disease.

Hiroko Matsumoto1, Debora A Clayton-Krasinski, Stephen A Klinge, Jaime A Gomez, Whitney A Booker, Joshua E Hyman, David P Roye, Michael G Vitale.   

Abstract

BACKGROUND: Orthopaedic intervention can have a wide range of functional and psychosocial effects on children with neuromuscular disease (NMD). In the multihandicapped child (Gross Motor Classification System IV/V), functional status, pain, psychosocial function, and health-related quality of life also have effects on the families of these child. The purpose of this study is to report the development and initial validation of an outcomes instrument specifically designed to assess the caregiver impact experienced by parents raising severely affected NMD children: the Assessment of Caregiver Experience with Neuromuscular Disease (ACEND).
METHODS: In the first part of this prospective study, 61 children with NMD and their parents were administered a range of earlier validated pediatric health measures. A framework technique was used to select the most appropriate and relevant subset of questions from this large set. Sensitivity analyses guided the development of a master question list measuring caregiver impact, excluding items with low relevance, and modifying unclear questions. In the second part of the study, the ACEND was administered to the caregivers of 46 children with moderate-to-severe NMD. Statistical analyses were conducted to determine validity of the instrument.
RESULTS: The resulting ACEND instrument included 2 domains, 7 subdomains, and 41 items. Domain 1, examining physical impact, includes 4 subdomains: feeding/grooming/dressing (6 items), sitting/play (5 items), transfers (5 items), and mobility (7 items). Domain 2, which examines general caregiver impact, included 3 subdomains: time (4 items), emotion (9 items), and finance (5 items). Mean overall relevance rating was 6.21 ± 0.37 and clarity rating was 6.68 ± 0.52 (scale 0 to 7). Multiple floor effects in patients with GMFCS V and ceiling effects in patients with GMFCS III were identified almost exclusively in motor-based items. Virtually no floor or ceiling effects were identified in the time, emotion or finance domains across GMFCS level.
CONCLUSIONS: The initial validation demonstrated that ACEND is a valid, disease-specific measure to quantify experience on caregivers of children with NMD. Larger groups of patients across NMD disease type are currently being tested to strengthen validity findings. Additionally, the ACEND is now being administered before and after orthopaedic interventions to determine responsiveness, which is critical to health outcomes research. LEVEL OF EVIDENCE/RELEVANCE: IIc.

Entities:  

Mesh:

Year:  2011        PMID: 21415688     DOI: 10.1097/BPO.0b013e31820fc522

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  7 in total

Review 1.  Condition-specific quality of life questionnaires for caregivers of children with pediatric conditions: a systematic review.

Authors:  Maria Yui Kwan Chow; Angela M Morrow; Spring Chenoa Cooper Robbins; Julie Leask
Journal:  Qual Life Res       Date:  2013-01-06       Impact factor: 4.147

2.  The effect of a flexible thoracolumbar brace on neuromuscular scoliosis: A prospective observational study.

Authors:  Joonyoung Jang; Yulhyun Park; Seungeun Lee; Seon Cho; Jun Chang Lee; Sunmok Hong; Jiwoon Lim; Ju Seok Ryu
Journal:  Medicine (Baltimore)       Date:  2021-08-13       Impact factor: 1.817

3.  Development of a proxy-reported scale to assess motor function in infants and young children with early-onset neuromuscular disorders.

Authors:  Carlos Capella-Peris; Magalie Emile-Backer; Monique O Shelton; Irene C Chrismer; Mary M Cosgrove; Roxanna M Bendixen; Katherine G Meilleur
Journal:  J Adv Nurs       Date:  2020-12-03       Impact factor: 3.057

Review 4.  The humanistic burden of Pompe disease: are there still unmet needs? A systematic review.

Authors:  Benedikt Schoser; Deborah A Bilder; David Dimmock; Digant Gupta; Emma S James; Suyash Prasad
Journal:  BMC Neurol       Date:  2017-11-22       Impact factor: 2.474

5.  INCEPTUS Natural History, Run-in Study for Gene Replacement Clinical Trial in X-Linked Myotubular Myopathy.

Authors:  James J Dowling; Wolfgang Müller-Felber; Barbara K Smith; Carsten G Bönnemann; Nancy L Kuntz; Francesco Muntoni; Laurent Servais; Lindsay N Alfano; Alan H Beggs; Deborah A Bilder; Astrid Blaschek; Tina Duong; Robert J Graham; Minal Jain; Michael W Lawlor; Jun Lee; Julie Coats; Charlotte Lilien; Linda P Lowes; Victoria MacBean; Sarah Neuhaus; Mojtaba Noursalehi; Teresa Pitts; Caroline Finlay; Sarah Christensen; Gerrard Rafferty; Andreea M Seferian; Etsuko Tsuchiya; Emma S James; Weston Miller; Bryan Sepulveda; Maria Candida Vila; Suyash Prasad; Salvador Rico; Perry B Shieh
Journal:  J Neuromuscul Dis       Date:  2022

6.  Evaluation of assessment of caregiver experience with neuromuscular disease: reliability and responsiveness of a new caregiver-reported outcome measure in patients with cerebral palsy.

Authors:  Nanfang Xu; Hiroko Matsumoto; Joshua Hyman; Benjamin Roye; Heakyung Kim; David P Roye
Journal:  Transl Pediatr       Date:  2020-08

7.  Estimation of the Quality-of-Life Impact of X-Linked Myotubular Myopathy.

Authors:  Andrew Lloyd; Daniel Aggio; Ted L Slocomb; Jun Lee; Alan H Beggs; Deborah A Bilder
Journal:  J Neuromuscul Dis       Date:  2021
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.